TERT promoter mutation status is an independent prognostic factor in cutaneous melanoma

被引：0
|
作者：
Griewank, K. [1 ]
Murali, R. [2 ]
Puig-Butille, J. [3 ]
Schilling, B. [1 ]
Livingstone, E. [1 ]
Potrony, M. [3 ]
Carrera, C. [3 ]
Schimming, T. [1 ]
Moeller, I. [1 ]
Schwamborn, M. [1 ]
Sucker, A. [1 ]
Hillen, U. [1 ]
Badenas, C. [3 ]
Malvehy, J. [3 ]
Zimmer, L. [1 ]
Scherag, A. [4 ]
Puig, S. [3 ]
Schadendorf, D. [1 ]
机构：
[1] Univ Klinikum Essen, Hautklin, Essen, Germany
[2] Mem Sloan Kettering, Pathol, New York, NY USA
[3] Univ Barcelona, Barcelona, Spain
[4] Univ Jena, Jena, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2014年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
FV11
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [11] Growth rate as an independent prognostic factor in localized invasive cutaneous melanoma
    Nagore, E.
    Martorell-Calatayud, A.
    Botella-Estrada, R.
    Guillen, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (05) : 618 - 620
  • [12] Age is an Independent Poor Prognostic Factor in Cutaneous Head and Neck Melanoma
    Stokes, William A.
    Lentsch, Eric J.
    [J]. LARYNGOSCOPE, 2014, 124 (02): : 462 - 465
  • [13] Classifying Melanoma by TERT Promoter Mutational Status
    Shaughnessy, Michael
    Njauw, Ching-Ni
    Artomov, Mykyta
    Tsao, Hensin
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (02) : 390 - +
  • [14] Telomere length and TERT promoter mutations in cutaneous melanoma
    Rachakonda, Sivaramakirishna
    Heidenreich, Barbara
    Nagore, Eduardo
    Kumar, Rajiv
    [J]. CANCER RESEARCH, 2017, 77
  • [15] TERT PROMOTER MUTATION IS A POOR PROGNOSTIC MARKER FOR GBMS AND INTERACTS WITH MGMT METHYLATION STATUS
    Arita, Hideyuki
    Yamasaki, Kai
    Nakamura, Taishi
    Shirahata, Mitsuaki
    Kobayashi, Keiichi
    Tamura, Kaoru
    Fukai, Junya
    Terakawa, Yuzo
    Mori, Kanji
    Nakamura, Hideo
    Yoshimoto, Koji
    Kanemura, Yonehiro
    Mukasa, Akitake
    Nagane, Motoo
    Ueki, Keisuke
    Komori, Takashi
    Nishikawa, Ryo
    Narita, Yoshitaka
    Ichimura, Koichi
    [J]. NEURO-ONCOLOGY, 2016, 18 : 108 - 108
  • [16] NRAS mutation as an independent prognostic factor for resectable Chinese acral melanoma
    Xu, Y.
    Lin, X.
    Liu, X.
    Sun, W.
    Hu, T.
    Yan, W.
    Wang, C.
    Zhang, X.
    Luo, Z.
    Chen, Y.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S697 - S697
  • [17] BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: Implications for melanoma staging and adjuvant therapy
    Barbour, Andrew P.
    Tang, Yue Hang
    Armour, Nicola
    Dutton-Regester, Ken
    Krause, Lutz
    Loffler, Kelly A.
    Lambie, Duncan
    Burmeister, Bryan
    Thomas, Janine
    Smithers, B. Mark
    Hayward, Nicholas K.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2668 - 2676
  • [18] TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy
    Martins, Francisco
    Martins, Cesar
    Fernandes, Margarida Sa
    Andrade, Maria Isabel
    Lopes, Jose Manuel
    Soares, Paula
    Populo, Helena
    [J]. DERMATOLOGY, 2022, 238 (03) : 507 - 516
  • [19] TERT promoter mutation is absent in oral mucosal melanoma
    Miao, Yuwen
    Wang, Runxiang
    Ju, Houyu
    Ren, Guoxin
    Guo, Wei
    Lyu, Jiong
    [J]. ORAL ONCOLOGY, 2015, 51 (08) : E65 - E66
  • [20] TERT promoter mutation is uncommon in acral lentiginous melanoma
    Liau, Jau-Yu
    Tsai, Jia-Huei
    Jeng, Yung-Ming
    Chu, Chia-Yu
    Kuo, Kuan-Ting
    Liang, Cher-Wei
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2014, 41 (06) : 504 - 508
12345